WT1 interacts with the splicing factor U2AF65 in an isoform-dependent manner and can be incorporated into spliceosomes
about
SKIP counteracts p53-mediated apoptosis via selective regulation of p21Cip1 mRNA splicingA novel SR-related protein is required for the second step of Pre-mRNA splicingMTA is an Arabidopsis messenger RNA adenosine methylase and interacts with a homolog of a sex-specific splicing factorZNF265--a novel spliceosomal protein able to induce alternative splicingA mammalian germ cell-specific RNA-binding protein interacts with ubiquitously expressed proteins involved in splice site selectionA novel zinc finger protein is associated with U7 snRNP and interacts with the stem-loop binding protein in the histone pre-mRNP to stimulate 3'-end processingThe acute myeloid leukemia-associated protein, DEK, forms a splicing-dependent interaction with exon-product complexesDespite WT1 binding sites in the promoter region of human and mouse nucleoporin glycoprotein 210, WT1 does not influence expression of GP210Mutual relationships between transcription and pre-mRNA processing in the synthesis of mRNAU2AF65 adapts to diverse pre-mRNA splice sites through conformational selection of specific and promiscuous RNA recognition motifs.Denys-Drash syndrome associated WT1 glutamine 369 mutants have altered sequence-preferences and altered responses to epigenetic modificationsIdentification of WTAP, a novel Wilms' tumour 1-associating proteinSubcellular localization of the human proto-oncogene protein DEKFunction of the transcriptional regulating protein of 132 kDa (TReP-132) on human P450scc gene expressionThe many facets of the Wilms' tumour gene, WT1Par4 is a coactivator for a splice isoform-specific transcriptional activation domain in WT1A zinc finger truncation of murine WT1 results in the characteristic urogenital abnormalities of Denys-Drash syndromeThe Wilms' tumor gene Wt1 is required for normal development of the retinaThe Wilms' tumor 1 (WT1) gene (+KTS isoform) functions with a CTE to enhance translation from an unspliced RNA with a retained intron.Serologic responses in patients with malignant mesothelioma: evidence for both public and private specificities.The Wilms tumour suppressor protein WT1 (+KTS isoform) binds alpha-actinin 1 mRNA via its zinc-finger domain.SRRM2, a potential blood biomarker revealing high alternative splicing in Parkinson's disease.Kidney development branches out.PPARbeta activation inhibits melanoma cell proliferation involving repression of the Wilms' tumour suppressor WT1.Analysis of mutant phenotypes and splicing defects demonstrates functional collaboration between the large and small subunits of the essential splicing factor U2AF in vivo.Classification of a frameshift/extended and a stop mutation in WT1 as gain-of-function mutations that activate cell cycle genes and promote Wilms tumour cell proliferationPresence of WT1, the Wilm's tumor suppressor gene product, in nuclear poly(A)(+) ribonucleoprotein.PRCC, the commonest TFE3 fusion partner in papillary renal carcinoma is associated with pre-mRNA splicing factors.The predominant WT1 isoform (+KTS) encodes a DNA-binding protein targeting the planar cell polarity gene Scribble in renal podocytes.Molecular genetics of chromosome translocations involving EWS and related family members.The Wilms tumor suppressor WT1 directs stage-specific quiescence and differentiation of human hematopoietic progenitor cells.Requirement of WT1 for gonad and adrenal development: insights from transgenic animals.Biochemical function of female-lethal (2)D/Wilms' tumor suppressor-1-associated proteins in alternative pre-mRNA splicing.Identification of a DNA-binding site and transcriptional target for the EWS-WT1(+KTS) oncoproteinPsip1/Ledgf p52 binds methylated histone H3K36 and splicing factors and contributes to the regulation of alternative splicing.The Wilms' Tumor Gene WT1 - 17AA/- KTS Splice Variant Increases Tumorigenic Activity Through Up-Regulation of Vascular Endothelial Growth Factor in an In Vivo Ovarian Cancer ModelRNA induces conformational changes in the SF1/U2AF65 splicing factor complexOxygen-Dependent Gene Expression in Development and Cancer: Lessons Learned from the Wilms' Tumor Gene, WT1Nuclear protein TIA-1 regulates COL2A1 alternative splicing and interacts with precursor mRNA and genomic DNA.TBX3 regulates splicing in vivo: a novel molecular mechanism for Ulnar-mammary syndrome.
P2860
Q24298821-ACE0268A-B99B-4D95-AADA-9477C67CC78EQ24299148-76725CDD-68CF-4BF1-978A-6F5C2A43F91EQ24650812-BD9E7EC7-CFE9-40A6-84A3-A97B902FA63CQ24654069-93820092-82D6-481A-8471-1FC05062F032Q24670000-C3D2FF7F-E1AB-4BC3-BA38-15DF4B0CE1AAQ24672946-FF6FF1F1-2FD8-48FF-94B0-259D452DD37CQ24684940-192ED489-03FD-44D8-B0EE-A1B60A65CF55Q24803653-50D9AAFC-6995-4E57-8CCA-BB9515989D2DQ26851218-4FEE1D4E-685A-479D-AB15-DC8EC298CC73Q27676123-618B10E7-BAC0-4D00-9A4C-FA7031F978EDQ27728005-62CEAF40-E914-4382-A485-62BC047033DCQ28139416-3CAC7C18-D3E5-4308-8C41-045C96EB9B1BQ28186821-B3F954A0-F63A-4314-AAC4-A10535751F5AQ28203368-AEDF3E02-34AF-4361-9CB5-C73831C5D7D2Q28264516-C556AAA8-E34F-4889-8E9D-7BD710535F71Q28346512-6F1A0B34-D622-44AA-876F-7562F2B12DB7Q28584838-D71778C8-2DC8-426D-8E12-7329963F7ACBQ28590668-1CB1839A-E4BD-4BED-B948-1B7516B34E52Q30440624-0A89A07B-D3AE-43CD-85E0-2CA6A9A12CCBQ30863574-063B4D47-A142-4A0D-B64E-0D3F03C4C2FEQ33266516-885F79CC-6158-4A3B-92F4-379ED8469DB8Q33531733-2FC76A28-9E84-47DF-BDDD-DFF97A9745BDQ33633117-4DC13D7C-5660-4981-AE79-4BC71756586EQ33742630-DEF7F6F2-9C05-4B52-B262-DFE775067073Q33763807-1048CCEC-597F-4279-90CB-4C808E9F3B60Q33847590-0D57CD8D-2122-4E27-9146-F75DBA65CA8CQ33883341-154D6795-275B-44A8-844E-9CB9852D9EBCQ33943447-BBA165BD-61E2-4533-B3A1-319FF1302906Q34001125-27EF5E22-1647-41A2-9D0D-BA63C2DC88A4Q34051653-48922964-E468-43C4-9088-C78FD2D3B168Q34077533-92EB0344-BE80-4010-B07E-9AF14ED77CC9Q34150371-1C28511E-2E28-4D1E-9CA3-8C9AEC45B9EDQ34160093-E0062C3B-80E8-480B-8FCF-6C83296D853AQ34223145-B3124374-679C-4740-8EA2-FF713A44AF95Q34276472-03CB543A-7B2B-4F15-AED2-4F675BAC36BFQ34478581-710F0EB2-143A-45CE-9EA2-0634836028BFQ34566006-99FB47CE-F828-44D9-A6C5-EDB9AC9D1841Q34617481-49E25824-F20A-47F9-A953-CE11B2247A78Q34639599-7F266510-CBE9-4E2B-8A00-E83422750841Q35133477-186FAB7A-F80B-4E6D-8CE6-910F91D6F33A
P2860
WT1 interacts with the splicing factor U2AF65 in an isoform-dependent manner and can be incorporated into spliceosomes
description
1998 nî lūn-bûn
@nan
1998 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
WT1 interacts with the splicin ...... incorporated into spliceosomes
@ast
WT1 interacts with the splicin ...... incorporated into spliceosomes
@en
WT1 interacts with the splicin ...... incorporated into spliceosomes
@nl
type
label
WT1 interacts with the splicin ...... incorporated into spliceosomes
@ast
WT1 interacts with the splicin ...... incorporated into spliceosomes
@en
WT1 interacts with the splicin ...... incorporated into spliceosomes
@nl
prefLabel
WT1 interacts with the splicin ...... incorporated into spliceosomes
@ast
WT1 interacts with the splicin ...... incorporated into spliceosomes
@en
WT1 interacts with the splicin ...... incorporated into spliceosomes
@nl
P2093
P2860
P921
P3181
P356
P1433
P1476
WT1 interacts with the splicin ...... incorporated into spliceosomes
@en
P2093
P2860
P304
P3181
P356
10.1101/GAD.12.20.3217
P407
P577
1998-10-15T00:00:00Z